Report Detail
Global (United States, European Union and China) Fexofenadine Market Research Report 2019-2025
- RnM3692405 |
- 23 August, 2019 |
- Global |
- 122 Pages |
- QYResearch |
- Chemical & Material
Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker
In 2019, the market size of Fexofenadine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fexofenadine.
This report studies the global market size of Fexofenadine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Fexofenadine production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical
Market Segment by Product Type
Purity:98%
Purity:>98%
Market Segment by Application
Hay Fever Treatment
Urticaria Treatment
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Fexofenadine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Fexofenadine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Fexofenadine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Fexofenadine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Purity:98%
- 1.3.3 Purity:>98%
- 1.4 Market Segment by Application
- 1.4.1 Global Fexofenadine Market Share by Application (2019-2025)
- 1.4.2 Hay Fever Treatment
- 1.4.3 Urticaria Treatment
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Fexofenadine Production Value 2014-2025
- 2.1.2 Global Fexofenadine Production 2014-2025
- 2.1.3 Global Fexofenadine Capacity 2014-2025
- 2.1.4 Global Fexofenadine Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Fexofenadine Market Size CAGR of Key Regions
- 2.2.2 Global Fexofenadine Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Fexofenadine Capacity by Manufacturers
- 3.1.2 Global Fexofenadine Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Fexofenadine Revenue by Manufacturers (2014-2019)
- 3.2.2 Fexofenadine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Fexofenadine Market Concentration Ratio (CR5 and HHI)
- 3.3 Fexofenadine Price by Manufacturers
- 3.4 Key Manufacturers Fexofenadine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Fexofenadine Market
- 3.6 Key Manufacturers Fexofenadine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Purity:98% Production and Production Value (2014-2019)
- 4.1.2 Purity:>98% Production and Production Value (2014-2019)
- 4.2 Global Fexofenadine Production Market Share by Type
- 4.3 Global Fexofenadine Production Value Market Share by Type
- 4.4 Fexofenadine Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Fexofenadine Consumption by Application
6 Production by Regions
- 6.1 Global Fexofenadine Production (History Data) by Regions 2014-2019
- 6.2 Global Fexofenadine Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Fexofenadine Production Growth Rate 2014-2019
- 6.3.2 United States Fexofenadine Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Fexofenadine Import & Export
- 6.4 European Union
- 6.4.1 European Union Fexofenadine Production Growth Rate 2014-2019
- 6.4.2 European Union Fexofenadine Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Fexofenadine Import & Export
- 6.5 China
- 6.5.1 China Fexofenadine Production Growth Rate 2014-2019
- 6.5.2 China Fexofenadine Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Fexofenadine Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Fexofenadine Consumption by Regions
- 7.1 Global Fexofenadine Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Fexofenadine Consumption by Type
- 7.2.2 United States Fexofenadine Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Fexofenadine Consumption by Type
- 7.3.2 European Union Fexofenadine Consumption by Application
- 7.4 China
- 7.4.1 China Fexofenadine Consumption by Type
- 7.4.2 China Fexofenadine Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Fexofenadine Consumption by Type
- 7.5.2 Rest of World Fexofenadine Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Viruj Pharma
- 8.1.1 Viruj Pharma Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Fexofenadine
- 8.1.4 Fexofenadine Product Introduction
- 8.1.5 Viruj Pharma Recent Development
- 8.2 Cemex Pharma
- 8.2.1 Cemex Pharma Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Fexofenadine
- 8.2.4 Fexofenadine Product Introduction
- 8.2.5 Cemex Pharma Recent Development
- 8.3 Smaart Pharmaceutticals
- 8.3.1 Smaart Pharmaceutticals Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Fexofenadine
- 8.3.4 Fexofenadine Product Introduction
- 8.3.5 Smaart Pharmaceutticals Recent Development
- 8.4 Titan Pharma
- 8.4.1 Titan Pharma Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Fexofenadine
- 8.4.4 Fexofenadine Product Introduction
- 8.4.5 Titan Pharma Recent Development
- 8.5 AFCL
- 8.5.1 AFCL Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Fexofenadine
- 8.5.4 Fexofenadine Product Introduction
- 8.5.5 AFCL Recent Development
- 8.6 Synkromax
- 8.6.1 Synkromax Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Fexofenadine
- 8.6.4 Fexofenadine Product Introduction
- 8.6.5 Synkromax Recent Development
- 8.7 Farmhispania
- 8.7.1 Farmhispania Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Fexofenadine
- 8.7.4 Fexofenadine Product Introduction
- 8.7.5 Farmhispania Recent Development
- 8.8 Gen Pharma
- 8.8.1 Gen Pharma Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Fexofenadine
- 8.8.4 Fexofenadine Product Introduction
- 8.8.5 Gen Pharma Recent Development
- 8.9 Admiron Life Sciences Private Limited
- 8.9.1 Admiron Life Sciences Private Limited Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Fexofenadine
- 8.9.4 Fexofenadine Product Introduction
- 8.9.5 Admiron Life Sciences Private Limited Recent Development
- 8.10 JRC
- 8.10.1 JRC Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Fexofenadine
- 8.10.4 Fexofenadine Product Introduction
- 8.10.5 JRC Recent Development
- 8.11 Archerchem
- 8.12 Sibram
- 8.13 Sumitomo Chemical
- 8.14 Panchsheel
- 8.15 CAMEO HEALTH CARE
- 8.16 CEPiA-Sanofi
- 8.17 Va Sudha Pharma Chem Limited
- 8.18 VPL Chemicals
- 8.19 Zhejiang Excel Pharmaceutical
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Fexofenadine Capacity, Production Forecast 2019-2025
- 9.1.2 Global Fexofenadine Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Fexofenadine Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Fexofenadine Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Fexofenadine Production Forecast by Type
- 9.7.2 Global Fexofenadine Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Fexofenadine Sales Channels
- 10.2.2 Fexofenadine Distributors
- 10.3 Fexofenadine Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Fexofenadine. Industry analysis & Market Report on Fexofenadine is a syndicated market report, published as Global (United States, European Union and China) Fexofenadine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Fexofenadine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
